进展期胃癌术后调强放疗加同期口服替吉奥胶囊化疗的临床疗效

目的:评价调强放疗加替吉奥胶囊配合中药调理胃肠道方案治疗进展期胃癌术后的临床疗效与不良反应.方法:68例进展期胃癌患者按先后入院顺序半随机分成观察组35例,术后4wk开始行靶区调强放射治疗(每日180Cgy,每周5次,总剂量45-55GY),对照组33例行常规放疗.两组均加口服替吉奥胶囊80mg/(m2·d),分2次口服,连服14d、21d为1周期,连用2个周期,放化疗期间给予中药调理胃肠道.治疗后进行两组临床疗效不良反应比较,治疗后3mo分析疗效和不良反应,治疗前、治疗后3mo、6mo、12mo随访进行Karnofsky生活质量评分.结果:两组临床疗效比较,观察组总有效率为51.43%,对照组为30.30%,两组临床疗效无统计学差异(P>0.05).Karnofsky评分结果表明,观察组与对照组分别治疗前与治疗后3mo、6mo、12mo比,有统计学差异(P<0.01,P<0.05),治疗后3mo、6mo、12mo观察组与对照组比,有统计学意义(P<0.02,P<0.05).两组血液学不良反应、胃肠道反应、周围神经不良反应比较,观察组比对照组小.结论:经过临床对照研究分析结果表明,进展期胃癌患者术后行调强放疗...

Efficacy and safety of intensitymodulated radiation therapy combined with gimeracil and oteracil potassium capsules in patients with advanced gastric cancer after surgery:a controlled clinical study

AIM:To evaluate the efficacy and safety of intensity-modulated radiation therapy combined with chemotherapy and herbal treatment versus conventional radiotherapy in patients with advanced gastric cancer after surgery.METHODS:Sixty-eight patients with advanced gastric cancer were divided into two groups:observation group (n=35) and control group (n=33).The observation group received intensity-modulated radiation therapy (180 Cgy daily,five times a week,total dose of 45-55 GY) 4 weeks after surgery,while the ...